@article{article, title = {{The cost-effectiveness of belimumab and voclosporin for patients with Lupus Nephritis in the United States}}, publisher = {{American Society of Nephrology (ASN)}}, url = {{https://eprints.whiterose.ac.uk/184882/ }}, year = {{2022}}, month = {{3}}, author = {{Mandrik O and Fotheringham J and Ren S and Tice JA and Chapman RH and Stevenson MD and Pearson SD and Herron-Smith S and Agboola F and Thokala P}}, doi = {{10.2215/cjn.13030921}}, volume = {{17}}, journal = {{Clinical Journal of the American Society of Nephrology}}, issue = {{3}}, pages = {{385-394}}, note = {{Accessed on 2025/08/11}}}